| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.67 | 0.005 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.58 | 0.02 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.54 | 0.04 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.52 | 0.04 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.51 | 0.09 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.47 | 0.1 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.42 | 0.1 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.34 | 0.1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.34 | 0.1 |